PureTech spinout Vedanta brings in $68M for microbiome drugs

Vedanta Biosciences, the microbiome startup founded and incubated by Daphne Zohar's PureTech Health, has raised $68 million to propel its bacteria-based drug candidates into late-stage clinical trials.

Source: bizjournals.com Health Care:Biotechnology headlines - July 21, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news